Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-24-002843
Filing Date
2024-11-12
Accepted
2024-11-12 10:32:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 6554
  Complete submission text file 0000315066-24-002843.txt   8310
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Subject) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-91006 | Film No.: 241444889
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)